Cleared Traditional

K251730 - LIA Console (542-7) (FDA 510(k) Clearance)

Dec 2025
Decision
196d
Days
Class 2
Risk

K251730 is an FDA 510(k) clearance for the LIA Console (542-7). This device is classified as a System, Imaging, Optical Coherence Tomography (oct) (Class II - Special Controls, product code NQQ).

Submitted by Leadoptik, Inc. (San Jose, US). The FDA issued a Cleared decision on December 19, 2025, 196 days after receiving the submission on June 6, 2025.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 892.1560. This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging..

Submission Details

510(k) Number K251730 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 06, 2025
Decision Date December 19, 2025
Days to Decision 196 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code NQQ - System, Imaging, Optical Coherence Tomography (oct)
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.1560
Definition This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging.